Top 5 Science Games Performance in Australia Q2 2022

In Q2 2022, the top 5 science games on a unified platform in Australia displayed diverse patterns in weekly downloads, revenue, and active users. Here’s a breakdown of their performance based on data from Sensor Tower.

Plague Inc. from Ndemic Creations witnessed a steady weekly revenue, peaking at around $2.4K in early April and ending the quarter at approximately $1.2K. Downloads started strong at 1.2K in late March but declined to 789 by the end of June. Meanwhile, active users decreased from 2.2K in late March to 1.6K by the end of the quarter.

Jetpack Joyride by Halfbrick Studios showed a downward trend in weekly revenue, starting at $1.2K in late March and dropping to about $759 by the end of June. Downloads peaked at 8.9K in early April but fell to 5.8K by the end of the quarter. Active users also showed a decline from 31.4K in late March to 33.7K by the end of June.

Cell to Singularity: Evolution from Computer Lunch experienced fluctuations in weekly revenue, peaking at approximately $1.2K in late April and ending the quarter at around $608. Weekly downloads showed a general upward trend, starting at 387 in late March and reaching 692 by the end of June. Active users remained relatively stable, ending the quarter at 4.4K.

Cell Expansion Wars from MOBIRIX had a mixed performance in weekly revenue, reaching a high of $764 in early May and ending the quarter at about $402. Downloads remained low, starting at 163 in late March and declining to 74 by the end of June. Active users decreased from 685 in late March to 448 by the end of the quarter.

Reactor Idle Tycoon by Robert Grzybek showed a stable weekly revenue around $200, ending the quarter at about $95. Downloads started at 191 in late March and dropped to 108 by the end of June. Active users remained steady, ending the quarter at 3.7K.

These insights highlight the varied performance trends of the top 5 science games in Australia during Q2 2022. For more detailed analysis and data, visit Sensor Tower.